- US-listed companies
- GlobeStar Therapeutics Corp
- Income statement
GlobeStar Therapeutics Corp (GSTC) Income statement
Market cap
$124.11K
P/E ratio
| 2016/09 | 2017/09 | 2018/09 | 2019/09 | 2020/09 | 2021/09 | 2022/09 | 2023/09 | |
| Revenue | - | - | 890 | 425 | 77 | - | - | - |
| Revenue growth (%) | - | - | - | - | - | - | ||
| Cost of revenue | - | - | 207 | 154 | 37,682 | 2,412 | - | - |
| Gross profit | - | - | 683 | 271 | -37,605 | -2,412 | - | - |
| Gross margin (%) | - | - | - | - | - | |||
| Operating margin (%) | - | - | - | - | - | |||
| Operating expenses | 155,480 | 460,909 | - | - | - | - | - | - |
| Operating income | -155,480 | -460,909 | -351,052 | -315,870 | -303,671 | -9,094,229 | -1,265,065 | -1,864,370 |
| Income before tax | -3,499,411 | -1,679,789 | - | - | - | - | - | - |
| Net income | -3,502,005 | -1,679,789 | -816,741 | -675,072 | -541,731 | -9,801,628 | -1,487,810 | -1,949,249 |
| Net income margin (%) | - | - | - | - | - |